
Conference Coverage
Latest News

Oct 06, 2025 | News
Valbenazine Linked to Better Physical and Emotional Well-Being in Tardive Dyskinesia

This Week on NeurologyLive® — October 6, 2025
Oct 06, 2025

Real-World EU Data Suggest Safety of High-Dose Apomorphine Infusion in Parkinson Disease
Oct 05, 2025

Risvodetinib Demonstrates Potential Functional Benefit in Early Parkinson Disease
Oct 05, 2025

Ecopipam Maintains Efficacy and Reduces Relapse Risk in Phase 3 Trial in Tourette Syndrome
Oct 05, 2025

Advertisement
Shorts

1:49
MDS 2025: Parkinson Disease and Brain Organization
an hour ago
by
A. Jon Stoessl, CM, MD(+1 more)

0:53
MDS 2025: Exercise and Diet's Impact on Parkinson Disease
a day ago
by
Jonas Hannestad, MD, PhD(+1 more)

1:21
Migraine Care Needs of the LGBTQIA+ Patient Population
5 days ago
by
Anna Pace, MD(+1 more)

1:16
Impact of Speech and Physical Therapy in Parkinson Disease
5 days ago
by
Cynthia Fox, PhD, CCC-SLP(+1 more)

1:33
Biomarkers to Guide Remyelination Strategies in MS
17 days ago
by
Ahmed Abdelhak, MD(+1 more)

1:07
Early Identification of Atypical Parkinsonian Syndromes
20 days ago
by
David Shprecher, DO, MSci, FAAN(+1 more)

1:28
Subjective Cognitive Complaints During the Interictal Period in Migraine
24 days ago
by
Laura Sebrow, PhD(+1 more)

1:10
Consensus Definitions for Refractory and Resistant Migraine
24 days ago
by
Jennifer Robblee, MD(+1 more)

1:10
The Future of Migraine Treatment
24 days ago
by
Patricia Pozo-Rosich, MD, PhD(+1 more)

1:10
Understanding Adolescent Migraine Suffering
24 days ago
by
Patricia Pozo-Rosich, MD, PhD(+1 more)